RSAD2 and coinfection: Collectively, these findings establish a robust molecular framework for understanding GV and HPV16 co-infection pathogenesis and highlight IFIT1 and RSAD2 as promising diagnostic biomarkers and therapeutic targets in HPV-related diseases.